274
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, self-assembly and drug release study of a new dual-responsive biocompatible block copolymer containing phenylalanine derivative

, , , &
Pages 792-803 | Received 10 May 2021, Accepted 03 Jun 2021, Published online: 13 Jul 2021
 

Abstract

Stimuli-responsive polymers as drug delivery vehicles have generated remarkable interest among polymer researchers during the last decade. In the present work, we report the synthesis of a new water soluble pH- and thermo-responsive biocompatible block copolymer containing phenylalanine derivatives. The block copolymer formed micelle-like self-assembled nanoparticles above critical aggregation concentration, as confirmed from fluorescence spectroscopy, DLS, and AFM studies. The self-assembly behavior was dependent on the pH and temperature of the aqueous media. These self-assembled micellar nanoparticles were capable of encapsulating hydrophobic drugs as demonstrated by the significantly higher loading capacity value of Doxorubicin (DOX) compared to commonly reported values in the literature. The release of DOX from the nanoparticles was favored at lower pH and higher temperature, a condition prevalent in cancer cells. Biocompatibility of the block copolymer and the effectiveness of the nanoparticles in potential cancer therapy were established by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) studies using non-cancerous murine fibroblasts L929 cells and breast cancer cell line MDA MB 231 at 37 °C and 42 °C. The cytotoxicity of DOX loaded polymer nanoparticles was found to be more effective at 42 °C compared to 37 °C. Thus, these micellar nanoparticles hold promise in drug delivery application in cancer therapy.

Graphical Abstract

Additional information

Funding

Financial support from the Science and Engineering Research Board, Government of India (Project Ref No: EMR/2016/007040) is acknowledged. G.B. and P. S. acknowledge IIT Kharagpur for research fellowships.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.